A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
about
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
A Randomized, Double-Blind Tri ...... Product in Healthy Adult Males
@en
type
label
A Randomized, Double-Blind Tri ...... Product in Healthy Adult Males
@en
prefLabel
A Randomized, Double-Blind Tri ...... Product in Healthy Adult Males
@en
P2093
P50
P1433
P1476
A Randomized, Double-Blind Tri ...... Product in Healthy Adult Males
@en
P2093
Sinhye Kim
Sunyoung Yu
P304
P356
10.1007/S40259-019-00340-X
P577
2019-04-01T00:00:00Z